Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Platelet-rich plasma mixed-fat grafting: a reasonable prosurvival strategy for fat grafts?

Serra-Mestre JM., Serra-Renom JM., Martinez L., Almadori A., D'Andrea F.

Narrative Review on Chronic Wound, published in Aesthetic Plast Surg (2014) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Aesthetic Plast Surg (2014)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
25028112
DOI
10.1007/s00266-014-0374-7
Citations
41

Abstract (original English)

Background One of the most interesting developments in practical applications of fat grafting in recent years is the use of prosurvival strategies to improve maintenance of volume. Platelet-rich plasma (PRP) plays a decisive role in the repair and regeneration of different tissues via the activation and secretion of a great variety of growth factors and other cytokines stored in the alpha-granules of the platelets. This review aimed to assess the efficacy of PRP mixed-fat grafting as a prosurvival strategy for fat grafts. Methods Online searches of the Cochrane Library and MEDLINE until January 2014 were conducted. The review included studies with at least one clinical end point in which the effect of PRP on the absorption and viability of the fat graft could be assessed. Results The review comprised 6 preclinical studies with a control group and 9 clinical studies of humans. It also included comparative studies performed with other prosurvival strategies for fat grafts, such as combination with the stromal vascular fraction and second-generation PRP, also called "platelet-rich fibrin." The results indicate that PRP may have a dose-dependent positive effect on fat grafts and suggest low complication rates. Conclusions The development of new growth factor delivery systems or cell therapies to enrich fat grafts is an area that merits further research.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdipose TissueGraft SurvivalHumansPlatelet-Rich PlasmaWound Healing

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research